Details for New Drug Application (NDA): 074166
✉ Email this page to a colleague
NDA 074166 describes TOPOSAR, which is a drug marketed by Teva Parenteral and is included in one NDA. Additional details are available on the TOPOSAR profile page.
The generic ingredient in TOPOSAR is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.
The generic ingredient in TOPOSAR is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.
Summary for 074166
| Tradename: | TOPOSAR |
| Applicant: | Teva Parenteral |
| Ingredient: | etoposide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 074166
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/ML | ||||
| Approval Date: | Feb 27, 1995 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
